GenMont Biotech Inc
TWSE:3164

Watchlist Manager
GenMont Biotech Inc Logo
GenMont Biotech Inc
TWSE:3164
Watchlist
Price: 18.35 TWD 0.82% Market Closed
Market Cap: 1.6B TWD

Wall Street
Price Targets

Price Targets Summary
GenMont Biotech Inc

There are no price targets for GenMont Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GenMont Biotech Inc Competitors:
Price Targets
VNDA
Vanda Pharmaceuticals Inc
36% Upside
LGND
Ligand Pharmaceuticals Inc
31% Upside
CUV
Clinuvel Pharmaceuticals Ltd
111% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
66% Upside
4974
Takara Bio Inc
40% Upside
TWST
Twist Bioscience Corp
24% Upside
EDT
Spectral Medical Inc
120% Upside
397030
AprilBio Co Ltd
14% Downside

Revenue
Forecast

Revenue Estimate
GenMont Biotech Inc

Revenue forecast
is not available for
GenMont Biotech Inc

Operating Income
Forecast

Operating Income Estimate
GenMont Biotech Inc

Operating Income forecast
is not available for
GenMont Biotech Inc

Net Income
Forecast

Net Income Estimate
GenMont Biotech Inc

For the last 13 years the compound annual growth rate for GenMont Biotech Inc's net income is 3%. The projected CAGR for the next 11 years is 0%.

3%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GenMont Biotech Inc's stock price target?
Not Available

GenMont Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is GenMont Biotech Inc's Net Income forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for GenMont Biotech Inc's net income is 3%. The projected CAGR for the next 11 years is 0%.

Back to Top